Kyverna Therapeutics, Inc. (KYTX) Operating income 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual operating income history from SEC filings — each fiscal year as reported.
-$169.8MFY2025 · since FY2023: -$62.4M → -$169.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$169.8M | -19.1% |
| FY2024 | -$142.6M | -128.5% |
| FY2023 | -$62.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice